NEW YORK (GenomeWeb) – N-of-One said today that it has signed an agreement to provide clinical interpretation support for the Mayo Clinic's molecular diagnostics testing.
N-of-One said that it will assist Mayo Medical Laboratories, a reference lab within Mayo Clinic's Department of Laboratory Medicine and Pathology, with biological and clinical knowledge and in identifying therapeutic options and potential clinical trials for patients who have their tumors sequenced. The Lexington, Mass.-based bioinformatics firm also will provide support services for Mayo's Center for Individualized Medicine.
Further terms of the alliance were not disclosed.
"With the rapidly increasing volume of clinical and scientific data, and hundreds of drugs currently in clinical trials, the task of interpreting molecular test results has become increasingly challenging," N-of-One CEO Chris Cournoyer said in a statement. "We are committed to providing scalable, cost-effective genomic clinical decision support that delivers valuable analysis and interpretation of the relevant clinical data to support oncologists in making molecularly informed treatment decisions for their patients."
N-of-One recently signed similar deals with the Dartmouth-Hitchcock Medical Center and with Cedars-Sinai Medical Center's Cancer Institute.